MVA Members

Novo Nordisk

For almost 100 years, Novo Nordisk has been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, such as insulin pens. Novo Nordisk treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From the labs to the factory floors, Novo Nordisk is discovering and developing innovative biological medicines and making them accessible to patients throughout the world.

Novo Nordisk Swedish affiliate is located in central Malmö and employs 75 people.